DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 04 · Volume 29 · July 1996 DOI: 10.1055/s-002-6373

Review

  • 127
    Michelini, S.; Cassano, G. B.; Frare, F.; Perugi, G.:

    Long-Term use of Benzodiazepines: Tolerance, Dependence and Clinical Problems in Anxiety and Mood Disorders

    • Original Paper

  • 135
    Winterer, C.; Herrmann, W. M.:

    Effect and Efficacy - On the Function of Models in Controlled Phase III Trials and the Need for Prospective Pharmacoepidemiological Studies

  • 144
    Stoll, S.; Scheuer, K.; Pohl, O.; Müller, W. E.:

    Ginkgo Biloba Extract (EGb 761) Independently Improves Changes in Passive Avoidance Learning and Brain Membrane Fluidity in the Aging Mouse

  • 150
    Stoppe, Gabriela; Sandholzer, H.; Staedt, J.; Winter, Silke; Kiefer, J.; Rüther, E.:

    Prescribing Practice with Cognition Enhancers in Outpatient Care: Are there Differences Regarding Type of Dementia? -Results of a Representative Survey in Lower Saxony, Germany

    • Comment

  • 142
    Krauth, J.:

    On the Importance of Phase III Studies - a Comment on Winterer and Herrmann

    • Case Report

  • 156
    Leinonen, E.; Lepola, U.; Koponen, H.:

    Substituting Carbamazepine with Oxcarbazepine Increases Citalopram Levels. A Report on Two Cases

  • 159
    Fink, M.:

    Toxic Serotonin Syndrome or Neuroleptic Malignant Syndrome?

    • Letter to the Editor

  • 162
    Benazzi, F.:

    Serotonin Syndrome with Moclobemide-Fluoxetine Combination